EOSS.OTC.PinkEos INC

10-K/A: EOS Inc. Files Amended 10-K Report, Citing Cybersecurity and Accounting Updates

Sentiment:

Annual Report Amendment


📋All filings for Eos INC

EOS Inc. has filed an amendment to its annual report on Form 10-K to include cybersecurity disclosures, revised internal control reporting, and additional financial details.

Capital raiseThe company's ability to continue as a going concern is dependent on generating revenues and raising capital.The company issued 345,000,000 shares of common stock to convert $420,900 of debt owed to a related party.The company issued 55,000,000 shares of common stock to convert $67,100 of debt owed to a related party.
Worse than expectedThe company's net sales decreased by 55% year-over-year, indicating a significant decline in business performance.The company's auditors have expressed substantial doubt about its ability to continue as a going concern, highlighting severe financial instability.The company has identified material weaknesses in its internal controls over financial reporting, indicating a lack of proper financial oversight.

Summary

  • EOS Inc. filed an amendment to its annual report on Form 10-K to address several items including cybersecurity risk management, internal control reporting, and financial disclosures.
  • The amendment includes the addition of Item 1.C Cybersecurity, as required by Regulation S-K, and updates to the management's report on internal control over financial reporting.
  • The company has also included revised disclosures regarding accounts receivable and the movements of provision for doubtful debts, correcting clerical errors from the original filing.
  • Revenue breakdowns by country are provided, as required by ASC 280-10-50-41(a), and additional disclosures are made under the Risk Factors section regarding the enforceability of civil liabilities.
  • The company's net sales for the year ended December 31, 2023, were $296,852, a decrease of 55% compared to $652,547 in 2022.
  • The gross profit for 2023 was $193,877, with a gross profit margin of 65%, compared to 44% in 2022.
  • The net loss for 2023 was $631,936, an improvement from the $1,912,159 loss in 2022.
  • The company's cash and cash equivalents were $14,307 at the end of 2023, compared to $18,169 at the end of 2022.
  • The company has a working capital deficit of $1,006,911 as of December 31, 2023.
  • The company's auditors have issued a going concern opinion, indicating substantial doubt about its ability to continue as a going concern without additional capital or revenue.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including a substantial revenue decline, a going concern warning, and material weaknesses in internal controls. While there are some positive aspects, such as improved gross profit margin and reduced losses, the overall outlook is concerning from an investment perspective.

Positives

  • The company's gross profit margin increased significantly from 44% to 65% year-over-year.
  • The net loss improved by 67% year-over-year, indicating a reduction in losses.
  • The company reversed certain provisions for doubtful debts, resulting in other income of $147,532.
  • The company reduced its selling, general, and administrative expenses by 56% year-over-year.
  • The company has taken steps to address cybersecurity risks by developing a risk management program.

Negatives

  • The company experienced a significant decrease in net sales of 55% year-over-year.
  • The company has a substantial working capital deficit of $1,006,911.
  • The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
  • The company has identified material weaknesses in its internal controls over financial reporting.
  • The company's cash and cash equivalents decreased from $18,169 to $14,307 year-over-year.

Risks

  • The company's ability to continue as a going concern is dependent on generating revenues and raising capital.
  • The company has material weaknesses in its internal controls over financial reporting.
  • The company is dependent on third-party manufacturers and suppliers.
  • The company faces competition from larger and more established companies.
  • The company's CFO is located in China, and a director is located in Hong Kong, which may pose challenges for enforcing civil liabilities.
  • The company relies on related party loans for working capital.

Future Outlook

The company intends to generate sufficient revenue and raise additional funds to support its operations, but there are no assurances to that effect. The company plans to focus on first-tier cities in China and develop online shopping centers in Southeast Asia starting in the second quarter of 2024.

Management Comments

  • Management has determined that our internal controls contain material weaknesses due to the absence of segregation of duties, as well as lack of qualified accounting personnel and excessive reliance on third party consultants for accounting, financial reporting and related activities.
  • Due to our size and nature, segregation of all conflicting duties is not possible.
  • Until we generate significantly greater revenues and employ accounting personnel, it is doubtful that we will be able implement any system which provides us with any degree of internal controls over financial reporting.

Industry Context

The company operates in the nutritional supplement market, which is expected to reach US$204.7 billion by 2026, with a CAGR of 7%. The company's focus on ginsenoside supplements aligns with the growing demand for health and wellness products, particularly in Asian markets.

Comparison to Industry Standards

  • The company's significant decrease in revenue and net loss is concerning when compared to industry leaders in the nutritional supplement market, such as Herbalife and Nu Skin, which typically report consistent revenue growth and profitability.
  • The company's gross profit margin of 65% is relatively high compared to some distributors, but the overall financial performance is weak due to high operating expenses and low sales volume.
  • The company's reliance on third-party manufacturers is common in the industry, but the lack of control over production costs and supply chain presents a significant risk.
  • The company's lack of internal controls and reliance on a single individual for key financial roles is not in line with best practices for public companies, especially those with international operations.
  • The company's going concern warning is a significant deviation from industry norms, as most established companies in the nutritional supplement sector have stable financial positions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessesThe company identified material weaknesses in its internal controls over financial reporting, including a lack of segregation of duties, inadequate review of financial statements, and the absence of independent directors.2023-12-31These weaknesses increase the risk of material misstatements in the financial statements.

Related Party Transactions

  • The company has advanced funds from its directors and shareholders Yu Cheng Yang for working capital purposes.
  • The company issued 345,000,000 shares of Common Stock to Co-Innovation Group Limited to convert outstanding debt owed to Mr. Yu-Cheng YANG in the amount of $420,900.
  • The company issued 55,000,000 shares of Common Stock to non-employees to convert outstanding debt owed to Mr. Yu-Cheng YANG in the amount of $67,100.

Stakeholder Impact

  • Shareholders face significant risk due to the company's going concern status and material weaknesses in internal controls.
  • Employees may be concerned about the company's financial stability and future prospects.
  • Customers may be affected by potential disruptions in the company's operations.
  • Suppliers may face increased credit risk due to the company's financial challenges.
  • Creditors face a higher risk of non-payment due to the company's financial instability.

Next Steps

  • The company plans to focus on first-tier cities in China and develop online shopping centers in Southeast Asia starting in the second quarter of 2024.
  • The company intends to generate sufficient revenue and raise additional funds to support its operations.

Key Dates

DateDescription
2015-04-03EOS Inc. was incorporated in the State of Nevada.
2015-11-16Emperor Star International Trade Co., Ltd. was incorporated in Taiwan.
2016-11-18EOS Inc. formed EOS INC. TAIWAN BRANCH.
2017-05-03EOS Inc. acquired Emperor Star International Trade Co., Ltd.
2018-08-18The Company filed a Certificate of Amendment to its Articles of Incorporation.
2018-09-20The Company set up a wholly-owned subsidiary, EOS International Inc. (EOS(BVI)).
2019-03-01EOS(BVI) set up a wholly-owned subsidiary, Shanghai Maosong Co., Ltd (Maosong).
2020-05-26EOS Inc. increased its investment in Emperor Star.
2020-06-02EOS(BVI) and Shanghai Qifan Qiye Management Co., Ltd. resolved to change the registered capital of Maosong.
2021-03-16The Company filed a Certificate of Change to increase its authorized common stock.
2021-03-31The Company's board of directors and stockholders authorized a reverse stock split.
2021-04-07The reverse stock split became effective upon approval by FINRA.
2021-07-13EOS(BVI), MaoSong, and Qifan entered into a Shareholder Agreement.
2021-08-19The Company filed a Certificate of Designation to establish a Series A preferred stock.
2022-02-03The Company granted warrants to purchase 200,000 shares of common stock.
2022-05-19The Company issued restricted common stock to non-employees.
2023-07-01The Company assumes effective control of Emperor Star International Trade Co., Ltd.
2023-08-11The Company issued 21,000,000 of freely tradable common stock to non-employees as compensation.
2023-12-01The Company filed a Certificate of Change to increase its authorized common stock.
2023-12-05The Company issued 345,000,000 shares of Common Stock to convert debt owed to Mr. Yu-Cheng YANG.
2023-12-18The Company issued 55,000,000 shares of Common Stock to convert debt owed to Mr. Yu-Cheng YANG.
2024-03-27Employee count as of this date.
2024-03-31Number of common stock holders as of this date.
2024-04-16EOS Inc. filed its Original Form 10-K for the fiscal year ended December 31, 2023.
2024-05-30Date of this amended filing.

Keywords

cybersecurity, internal controls, financial reporting, ginsenoside supplements, nutritional supplements, revenue, net loss, going concern, working capital, debt conversion

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.